Close Menu

Chembio Diagnostics

Several companies will receive grants to develop hepatitis C molecular point-of-care and core antigen diagnostic assays.

The grant is the second in the last six months that the Paul G. Allen Family Foundation has awarded to Chembio for diagnostics development.

Grants awarded to Chembio, BD, and FIND will help fund new diagnostic tests for Ebola and other fever-inducing illnesses and feasibility studies to evaluate them.

NEW YORK (GenomeWeb News) – Genisphere said today it has licensed its 3DNA Signal Amplification technology to Chembio Diagnostics.

Chembio Diagnostics has published a study demonstrating the utility of its antibody-based Dual Path Platform point-of-care test for syphilis.

Agilent has named Lars Holmkvist as a senior vice president and president of its Diagnostics and Genomics group.

A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.

A new analysis finds some cancers receive more nonprofit dollars than others.

An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.

In Science this week: comparative analysis of sex differences in mammal gene expression, and more.